This is the second amendment to Q1 2025 results, revealing persistent internal control failures and a pattern of accounting errors affecting multiple periods (2024, 2025 annuals also being restated). The restatement itself is backward-looking but signals deep-seated control issues that raise governance concerns and could delay the planned Nasdaq uplisting. Monitor whether the company can execute the remediation plan and file a clean periodic report before the next earnings cycle.
Price Chart
Executive Summary
FDCTech filed Amendment No. 2 to its Q1 2025 10-Q, restating financial statements due to multiple errors. Corrections include reclassifying an $8,200,000 subscription receivable to contra-equity, recognizing 500,000 previously unrecorded shares, separately presenting $17.5M in restricted client funds, correcting noncontrolling interest and AOCI allocations, and adjusting other income/expense, which increased net income by $209,574. Management identified material weaknesses in internal controls over financial reporting, including subscription receivable classification, stock issuance tracking, restricted cash presentation, and noncontrolling interest allocation.
Key Facts
- Restatement corrects nine categories of errors in previously issued Q1 2025 financial statements, including subscription receivable reclassification, unrecorded stock, and client fund segregation.
- Restatement increased net income for Q1 2025 by $209,574 (from $104,548 to $314,122) via corrections to other income/expense.
- Material weaknesses identified in internal controls: subscription receivable classification, stock issuance tracking, restricted cash presentation, and noncontrolling interest allocation.
- Cash and cash equivalents restated down from $26,996,932 to $2,425,391 with $17,453,282 reclassified to restricted client funds.
- Subscription receivable of $8,200,000 reclassified from current asset to contra-equity, reducing total stockholders' equity.
- 500,000 shares of common stock issued in October 2021 were not previously recorded in the share register.
- Total revenue unchanged at $5,976,948 for Q1 2025; gross profit unchanged at $2,859,559.
- Related party advances corrected from $932,932 to $(6,780,895) in financing activities, reflecting $7,713,827 reclassification.
- Noncontrolling interest corrected to $14,199 at March 31, 2025.
- Company concurrently restating FY2024 and FY2025 annual financial statements, indicating broader accounting issues.
Financial Impact
Net income increased by $209,574 for Q1 2025; stockholders' equity reduced by $8,000,000 from subscription receivable reclassification; cash reclassified by $24,571,541 between cash and restricted cash; related party advances corrected by $7,713,827.
Risk Factors
- Multiple restatements erode investor confidence and may trigger SEC scrutiny or OTC Markets action.
- Material weaknesses in internal controls could delay the planned uplisting to a national securities exchange.
- Related party transactions and intercompany balances remain complex and may have further undisclosed adjustments.
- Pending litigation (Alkoby claim, FIAU penalties) adds legal overhang and potential cash outflow.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 10-Q/A Filing (Primary) | 0001493152-26-027765 |
| Exhibit: ex31-1.htm | 0001493152-26-027765 |
| Exhibit: ex31-2.htm | 0001493152-26-027765 |
| Exhibit: ex32-2.htm | 0001493152-26-027765 |
| Exhibit: ex32-1.htm | 0001493152-26-027765 |
| Document: 0001493152-26-027765-index-headers.html | 0001493152-26-027765 |
| Document: 0001493152-26-027765-index.html | 0001493152-26-027765 |
| Document: 0001493152-26-027765.txt | 0001493152-26-027765 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | 8-K | $3.99 | awaiting T+60 | — | $4.37 (+9.52%) |
Oct 2, 2026 24d ago | EFFECT | $2.01 | awaiting T+60 | — | $4.37 (+117.41%) |
Sep 24, 2026 4w ago | S-1/A | $2.85 | awaiting T+60 | — | $4.37 (+53.33%) |
Sep 22, 2026 4w ago | 8-K | $2.10 | awaiting T+60 | — | $4.37 (+108.10%) |
Sep 15, 2026 5w ago | S-1 | $0.9900 | awaiting T+60 | — | $4.37 (+341.41%) |
Sep 10, 2026 6w ago | 8-K | $0.9999 | awaiting T+60 | — | $4.37 (+337.04%) |
Aug 26, 2026 8w ago | 8-K | $1.25 | awaiting T+60 | — | $4.37 (−249.60%) |
Jun 23, 2026 17w ago | 8-K | $3.11 $0.9900 | ▲ +68.17% | ▲ +71.46% | $4.37 (−40.51%) |
Jun 23, 2026 17w ago | 10-K/A | $3.11 $0.9900 | ▲ +68.17% | ▲ +71.46% | $4.37 (−40.51%) |
Jun 8, 2026 20w ago | 8-K | $6.00 $1.00 | ▲ +83.33% | ▲ +87.41% | $4.37 (+27.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers